Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Q-Core targets ambulatory pump technology at US & EU markets

This article was originally published in Clinica

Executive Summary

Israeli pump technology specialist Q-Core (Ramat Gan) is targeting the launch of its AP 34-M multi-therapy infusion pump and EF 34-M enteral feeding pump in the US and EU markets this year. The products, based on Q-Core's proprietary electromagnetic flow control (EFC) technology, include software-controlled pump and valve technology and are designed to answer the growing need to reduce capital costs while enhancing patients' quality-of-life by treating them at alternative sites to hospitals.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT057386

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel